You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
昆藥集團(600422.SH):未來將充分利用集採中標及醫保解限兩大窗口期
格隆匯 05-26 11:13

格隆匯5月26日丨有投資者向昆藥集團(600422.SH)提問:注射用血塞通(凍幹)快速增長的原因?未來的發展預期?

昆藥集團回覆:公司緊抓注射用血塞通(凍幹)在多省區中成藥省際聯盟集採中標及進入醫保支付標準試點品種的政策契機,重點推進中標省份執標,穩步提升產品在相關市場佔有率,同時積極推動產品在各省的解限落地與執行,為增量盤穩步提速奠定基礎。2022年,注射用血塞通(凍幹)同比增長72.64%。未來,公司將充分利用集採中標及醫保解限兩大窗口期,穩步推進和開拓市場渠道,不斷提升產品市場佔有率,並努力夯實穩定針劑市場格局。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account